retatrutide lawsuit Retatrutide, a new weight loss drug not available on the market yet, is showing promising results in trials. @DrLaPook explains it's doing much more than what current medications can Retatrutide Access Warning #weightloss #elililly

While it stimulates GLP-1, it actually blocks the GIP hormone receptor

Microdosing a GLP-1 medication is an individual decision that warrants consideration of several factors such as medical history, weight loss goals, financial constraints, and each patients ability to manage off-label dosing instructions and guidelines

Note: Direct Meds received an FDA marketing language warning in September 2025 that has been remediated

And in a field as personal as weight management, nuance matters

This is why many people start with 10mg vials and transition to 30mg vials once they reach 5mg per week or higher

MeAgain is the second one